Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Moderna secures $1.5B lifeline as it looks to break even in 2028
At an analyst day event, Moderna said it wants to invest revenue from a hopefully expanded seasonal vaccine franchise into oncology and rare disease programs, to “set t...